(Headline USA) As America braces a new surge of COVID-19 cases caused by the fast-spreading but relatively mild omicron variant, doctors are warning of yet another challenge: the two standard drugs they’ve used to fight infections are unlikely to work against the new strain. For more than a year antibody drugs from Regeneron and Eli […] More
Leading Antibody Treatments May Be Useless Against Omicron
Reviewed by The News on Donal Trump
on
December 20, 2021
Rating:
No comments: